|
ENHANCED ACETYL- AND BUTYRYL- CHOLINESTERASE INHIBITOR |
|
Pincipal investigator : GUILLOU Catherine
|
|
CONTEXT
Memory
troubles linked to Alzheimer disease are known to be associated with the loss
of the cerebral cholineric functions through a drop in acetycholine
neuromediator. Current symptomatic therapy aims at increasing the level of
acetycholine by inhibiting acetylcholinesterase, the enzyme responsible for
acetylcholine degradation. There is currently a demande for an efficient safe
inhibitor and esay to synthesize as most of current commercialized inhibitors
are hard to synthesize and have side effets.
Pour lire la suite, merci de vous identifier ou de vous inscrire dans la zone de droite... |
